The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): A randomised placebo-controlled trial

  • Mike J. Crawford
  • , Verity Leeson
  • , Rachel Evans
  • , Barbra Barrett
  • , Aisling McQuaid
  • , Jack Cheshire
  • , Rahil Sanatina
  • , Gary Lamph
  • , Piyal Sen
  • , Katina Anagnostakis
  • , Louise Millard
  • , Inti Qurashi
  • , Fintan Larkin
  • , Nusrat Husain
  • , Paul Moran
  • , Thomas R.E. Barnes
  • , Carol Paton
  • , Zoe Hoare
  • , Marco Picchioni
  • , Simon Gibbon

Research output: Contribution to journalArticlepeer-review

78 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): A randomised placebo-controlled trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Psychology

Biochemistry, Genetics and Molecular Biology